Arcus Biosciences

Quarterly Financials

Values in thousands 2024-09-30 2024-06-30 2024-03-31 2023-12-31
Revenue
$48,000
$39,000
$145,000
$31,000
Gross Profit
48,000
37,000
142,000
26,000
EBITDA
-105,000
-91,000
20,000
-75,000
EBIT
-107,000
-93,000
17,000
-80,000
Net Income
-92,000
-93,000
-4,000
-81,000
Net Change In Cash
48,000
39,000
145,000
31,000
Free Cash Flow
25,000
-94,000
-6,000
-94,000
Cash
201,000
156,000
185,000
127,000
Basic Shares
91,400
91,100
86,200
75,000

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$117,000
$112,000
$382,882
$77,517
Gross Profit
-223,000
98,000
375,825
-81,483
EBITDA
-283,000
-250,000
61,962
-118,467
EBIT
-291,000
-264,000
54,905
-122,858
Net Income
-307,000
-267,000
53,000
-116,677
Net Change In Cash
117,000
112,000
382,882
77,517
Cost of Revenue
-22,699
115,478
Free Cash Flow
-330,000
426,000
-282,249
108,115
Cash
127,000
206,000
147,914
173,415
Basic Shares
74,000
72,000
73,966
54,787

Earnings Calls

Quarter EPS
2024-09-30
-$1
2024-06-30
-$1.02
2024-03-31
-$0.05
2023-12-31
-$1.08